Welcome!
iX Biopharma
Broker's Calls
PhillipCapital 'remains confident' in iX Biopharma’s growth prospects upon China agreement
PhillipCapital has kept its "buy" recommendation with the same target price of 44.5 cents.
April 08, 2021
Deals, joint ventures & alliances
iX Biopharma enters agreement with Chinese pharmaceutical distributor to tap China market
iX Biopharma has partnered with China Resources Pharmaceutical Group to distribute products in China.
April 06, 2021
Broker's Calls
973 Brokers' Digest
Take a look at these six stocks this week, including DBS, Starhub and ST Engineering.
February 26, 2021
Broker's Calls
iX Biopharma remains a 'buy' from PhillipCapital despite $2.8 million net loss in 1H21
PhillipCapital is maintaining its “buy” call on iX Biopharma, but at a lower target price of 44.5 cents.
February 22, 2021
New appointments
IX Biopharma appoints Eva Tan as CCO
Speciality pharmaceutical company iX Biopharma has appointed Eva Tan as its new chief commercial officer.
January 18, 2021
Positioning for the recovery
PhillipCapital eyes year-end STI at 3,200
“Investors are positioning ahead of the expected normality to pre-Covid-19 economic conditions," says PhillipCapital.
December 24, 2020
Company in the news
iX Biopharma obtains approval and registration of male erectile dysfunction drug in Singapore
The drug will be supplied via licensed medical practitioners in Singapore.
October 20, 2020
Broker's Calls
Phillip Securities initiates 'buy' for iX Biopharma on prospect of turning profitable in FY21
The biotech company could finally turn profitable in FY21 as revenue could be bumped up by as much as 250%, says the brokerage.
October 02, 2020
Company in the news
iX Biopharma secures Australia's GMP licence for its testing laboratory
Shares in iX Biopharma closed flat at 24 cents on September 25.
September 28, 2020
Company in the news
iX Biopharma secures Israel patent for WaferiX
iX Biopharma says its intellectual property rights for its sublingual wafer technology is now secured in five continents.
September 21, 2020